In the 1970’s, a new wave of drug innovation completely restructured the medical world. This new learning that transformed the industry was a radically new science known as molecular biology. With this came the breakthrough of recombinant DNA and genetic engineering [12]. These inventions ignited the advancement of major pharmaceutical companies such as Eli Lilly, Abbott, Upjohn, SmithKline, and Squibb at the time, which quickly adopted the new techniques to rise above competition [12].